Jade Biosciences (JBIO) entered into a securities purchase agreement with BB Biotech (BBAGF) for a private placement financing that is expected to ...
The latest price target for Jade Biosciences (NASDAQ:JBIO) was reported by Clear Street on November 25, 2025. The analyst firm set a price target for $25.00 expecting JBIO to rise to within 12 months ...
Jade Biosciences, Inc. (Nasdaq: JBIO), a biotechnology company focused on autoimmune disease therapies, has announced the successful completion of its reverse merger and its debut on Nasdaq, along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback